Skip to main content

Table 4 Global response rates by baseline pathogen in the MITT population and early switch subpopulation

From: Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial

 

MITT population

Early switch subpopulation

Baseline pathogen

EOT

EOS

EOT

EOS

 

n (%)

n (%)

n (%)

n (%)

 

[95% CI]*

[95% CI]*

[95% CI]*

[95% CI]*

C. albicans

    

 Subjects in analysis

92

84

41

40

 Success

80 (87.0)

63 (75.0)

36 (87.8)

33 (82.5)

[80.1–93.8]

[65.7–84.3]

[77.8–97.8]

[70.7–94.3]

 Failure

12 (13.0)

21 (25.0)

5 (12.2)

7 (17.5)

C. glabrata

    

 Subjects in analysis

52

48

18

17

 Success

45 (86.5)

31 (64.6)

16 (88.9)

10 (58.8)

[77.3–95.8]

[51.1–78.1]

[74.4–100.0]

[35.4–82.2]

 Failure

7 (13.5)

17 (35.4)

2 (11.1)

7 (41.2)

C. parapsilosis

    

 Subjects in analysis

34

32

18

18

 Success

26 (76.5)

22 (68.8)

16 (88.9)

15 (83.3)

[62.2–90.7]

[52.7–84.8]

[74.4–100.0]

[66.1–100.0]

 Failure

8 (23.5)

10 (31.3)

2 (11.1)

3 (16.7)

C. tropicalis

    

 Subjects in analysis

19

17

9

8

 Success

15 (78.9)

12 (70.6)

9 (100.0)

8 (100.0)

[60.6–97.3]

[48.9–92.2]

[100.0–100.0]

[100.0–100.0]

 Failure

4 (21.1)

5 (29.4)

0

0

C. krusei

    

 Subjects in analysis

10

10

3

3

 Success

6 (60.0)

5 (50.0)

3 (100.0)

3 (100.0)

[29.6–90.4]

[19.0–81.0]

[100.0–100.0]

[100.0–100.0]

 Failure

4 (40.0)

5 (50.0)

0

0

  1. *95% CI based on normal approximation to the binomial.
  2. Abbreviations used: CI, confidence interval; EOS, end of study; EOT, end of treatment; MITT, modified intent-to-treat.